SNCA and neurodegenerative disease: Neurodegenerative diseases characterized by the presence of SNCA/α-synuclein (synuclein, alpha) aggregates are classified as α-synucleinopathies, including Parkinson disease (PD) and dementia with Lewy bodies (DLB).